Home › Drug Codes › J Codes › J2468 · POSFREA
Updated October 1st, 2026

POSFREA J Code: J2468

Injection, palonosetron hydrochloride (posfrea), 25 micrograms

Advertisement POSFREA manufacturer announcement banner
Medicare Payment Limit ?
$54.086
/ HCPCS billing unit
APC Payment Limit ?
$54.086
/ HCPCS billing unit · APC 0815
ASP ?
$51.025
/ HCPCS billing unit
WAC ?
$63.068
/ HCPCS billing unit
AWP ?
$75.682
/ HCPCS billing unit
NDCs Crosswalked ?
1
View NDC crosswalk →

Drug & Product Overview

HCPCS Descriptor Injection, palonosetron hydrochloride (posfrea), 25 micrograms
HCPCS Added Date July 1, 2024
Manufacturer Avyxa Pharma
Route of Administration Intravenous
Generic Status Single-Source; Branded
Dosage Type Single-Dose
Dosage Form Injection, Solution

About POSFREA

Posfrea is a medication aligned to the HCPCS J Code: J2468 for billing, pricing, and reimbursement purposes in the United States. Classified under Anti-Emetic, it is administered via the intravenous route and manufactured by Avyxa Pharma.

According to CMS Drug Use Information: This medication is used to prevent nausea and vomiting caused by cancer drug treatment (chemotherapy). It is also used to prevent nausea and vomiting after surgery. Palonosetron works by blocking one of the body's natural substances (serotonin) that causes vomiting.

Disclaimer: This is a summary and does not contain all possible information about this product. For complete information about this product or your specific health needs, ask your healthcare professional.

NDC Code Information

Based on publicly available CMS files. The list of NDCs below is not exhaustive.

NDC Code Package Manufacturer HCPCS Units WAC AWP
83831-0105-01
250 MCG / 5 ML posfrea Intravenous Injection 250 MCG/5ML - 1 VIAL, SINGLE-DOSE in 1 CARTON (83831-105-01) / 5 mL in 1 VIAL, SINGLE-DOSE
Avyxa Pharma, LLC 10 $630.68 $63.068 / unit $756.82 $75.682 / unit

Effective 7/1/26 (WAC & AWP)

Login for the full NDC crosswalk View pricing, complete NDC-to-HCPCS alignments, and package details.
Login →

POSFREA Pricing & Reimbursement

J2468 Private Payer Reimbursement
$60.38 / HCPCS unit as of Jan 2026

National median reimbursement across major commercial payers.

Create an account on PayerPrice for more information →
UnitedHealthcare, BlueCross BlueShield, Aetna, Cigna

Historical Graphing and Billing Calculator

HCPCS Units
%
Common:

Estimates only. Payer reimbursement varies by contract, site of care, and sequestration.

Estimated Reimbursement

Palonosetron HCL 505(b)(2) Information:

HCPCS Code Manufacturer Active Ingredient HCPCS Description
J2468 Avyxa Pharma Palonosetron HCL Injection, palonosetron hydrochloride (posfrea), 25 micrograms

POSFREA Claims Performance

Claims from Jan 2026 – Aug 2026
Claim Denial Rate 9.71%
Avg. Days to File 7.0days
Avg. Days to Pay 25.6days

Real-world claims performance from FocalPoint, OnPoint Oncology's reimbursement analytics platform, with claims data accrued at the clearing house level.

Explore J2468 claims analytics on FocalPoint →
OnPoint Oncology

POSFREA CPT Administration Codes

The below list of CPT codes is intended for informational purposes only and may not be exhaustive. CPT® codes and descriptions are copyright American Medical Association (AMA). All rights reserved.

CPT Code Description
96374 Therapeutic, prophylactic, or diagnostic injection (specify substance or drug), IV push, single, or initial substance/drug
Not on the CMS JW / JZ list

This product is new and does not yet appear on the CMS list of HCPCS pertaining to single-dose containers. Wastage billing guide →

POSFREA Medically Unlikely Edits (MUE)

The most billing units of J2468 Medicare will pay for one patient in one day, as published by CMS. 1 unit = 25 mcg.

Practitioner Office & Hospital Outpatient
10 units / day
= 250 mcg per day

MAI 3 · Date of Service Edit: Clinical. Per-day limit based on clinical expectations; excess units are denied but may be appealed with documentation of medical necessity. See all MUE limits →

mcg Enter a dose to see how many billing units it is and whether it is under the limit.

POSFREA Clinical Information

Indications and drug classification.

Treated Diseases & Conditions

This list of indications is not exhaustive and may be subject to errors. The information on BuyandBill.com is intended for informational purposes only and should not be used for medical advice.

Chemotherapy-Induced Nausea and Vomiting (CINV) Postoperative Nausea and Vomiting (PONV)
Drug Class
Serotonin 3 Receptor Antagonists [MoA]Serotonin-3 Receptor Antagonist [EPC]

Login for BuyandBill.com Analytics

Unlock deeper insights with BuyandBill’s Comparative Report!

  • Compare ASP, WAC, and AWP across drugs.
  • Visualize Drug Price Movement Over Time
  • Tailor reports to drug class, manufacturer, or HCPCS Code.
  • Compare Biosimilar and 505(b)(2) products.

Frequently Asked Questions

Is there an available POSFREA billing and coding guide?
Billing and coding information for POSFREA can be found through Avyxa. Visit Here →
Are there any available POSFREA patient assistance programs?
POSFREA patient assistance information can be found through Avyxa. Visit Here →
Where can I find POSFREA prescribing information?
Prescribing information for POSFREA can be found at the link below. Visit Here →
Where can I find POSFREA side effect information?
Our team has not yet identified a source of side effects information for POSFREA. Please check back in a few weeks.
Does billing POSFREA require JZ/JW wastage modifiers?
CMS does not include POSFREA (J2468) on its list of HCPCS pertaining to single-dose containers. Per CMS guidelines, the JZ/JW wastage modifiers may not apply when billing J2468. For more information, visit the link below.

About BuyandBill.com:

The BuyandBill.com team is dedicated to delivering high-quality coding and billing information for office-administered drugs. We continuously research HCPCS-coded medications to expand our resources and ensure data accuracy. Manufacturers: click here to sponsor your medication, and we will ensure the most accurate and detailed information is displayed.